The role of statins in delaying Alzheimer’s disease. Circulating cholesterol levels, ApoE genotype and initial dementia severity influence the level of benefit produced by atorvastatin in mild-to-moderate AD: Results of the ADCLT

✍ Scribed by D. Larry Sparks; Donald J. Connor; Marwan N. Sabbagh; Jean Lopez; Patrick Browne; Bob Petersen; Dawn Wasser; Sherry Johnson-Traver

• Book ID: 118461950
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 45 KB
• Volume: 1
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2005.06.321